TrialMolecular psychiatry2024

Oral esketamine in patients with treatment-resistant depression: a double-blind, randomized, placebo-controlled trial with open-label extension.

Sanne Y Smith-Apeldoorn et al.PubMed ↗Publisher ↗

No numbers read from the abstract.